Showing results (2861-2870 of 9,184) with videos related to
Sort By:
Pageof 919
Cancer Medicine|March 1, 2020
Significance of examined lymph nodes number and metastatic lymph nodes ratio in overall survival and adjuvant treatment decision in resected laryngeal carcinomaXiaoke Zhu, Min Zhao, Liang Zhou, et al.Cancer Medicine|December 17, 2019
Rectal NETs and rectosigmoid junction NETs may need to be treated differentlyWen Cai, Weiting Ge, Hanguang Hu, et al.Cancer Medicine|November 3, 2020
Comprehensive subgroup analyses of survival outcomes between clear cell renal cell adenocarcinoma and papillary renal cell adenocarcinomaJingyi Huang, Da Huang, Jiaqi Yan, et al.Cancer Medicine|November 4, 2020
Intraoperative ipsilateral subclavian port catheter implantation in resectable breast cancer patients: A novel, safe, and convenient clinical practiceFeng Ye, Yubo Liu, Ping Yu, et al.Cancer Medicine|November 4, 2020
Hypercalcemia caused by humoral effects and bone damage indicate poor outcomes in newly diagnosed multiple myeloma patientsLi Bao, Yutong Wang, Minqiu Lu, et al.Cancer Medicine|November 4, 2020
LncRNA MALAT1 accelerates non-small cell lung cancer progression via regulating miR-185-5p/MDM4 axisDan Wang, Suhong Zhang, Min Zhao, et al.Cancer Medicine|April 8, 2020
Optimal treatment strategy with nilotinib for patients with newly diagnosed chronic-phase chronic myeloid leukemia based on early achievement of deep molecular response (MR4.5 ): The phase 2, multicenter N-Road studyKaichi Nishiwaki, Kei-Ji Sugimoto, Shigehisa Tamaki, et al.Cancer Medicine|November 13, 2019
Potent anti-myeloma activity of the TOPK inhibitor OTS514 in pre-clinical modelsAndrew T Stefka, David Johnson, Shaun Rosebeck, et al.Cancer Medicine|November 13, 2019
A novel nomogram to predict the local tumor progression after microwave ablation in patients with early-stage hepatocellular carcinoma: A tool in prediction of successful ablationChao An, Songsong Wu, Zhimei Huang, et al.Cancer Medicine|January 29, 2020
LncRNA LOC285194 modulates gastric carcinoma progression through activating Wnt/β-catenin signaling pathwayBingzheng Zhong, Qiang Wang, Jiali He, et al.Pageof 919